Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
What’s Your Call?
Collective community sentiment on Sakar Healthcare Ltd
Your Vote -
Buy
16.67%
Hold
50.00%
Sell
33.33%
16.67%
6 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
NaN%
Sell Order Quantity
NaN%
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Option Chain
Analyzes market sentiment, predicts Sakar Healthcare Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Sakar Healthcare Q4 net profit jumps 84.62% at Rs 5.76 cr
-
Sakar Healthcare - Statement of deviation(s) or variation(s) under Reg. 32
-
Sakar Healthcare - Outcome of Board Meeting
-
Sakar Healthcare - Outcome of Board Meeting
-
Sakar Healthcare - Board Meeting Intimation
-
Sakar Healthcare - Disclosure under SEBI Takeover Regulations
-
Sakar Healthcare - Updates
-
Sakar Healthcare - Updates
-
Sakar Healthcare has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025
-
Sakar Healthcare - Updates
-
Sakar Healthcare - Updates
-
Sakar Healthcare - Trading Window-XBRL
-
Sakar Healthcare - Trading Window
Key fundamentals
Evaluate the intrinsic value of Sakar Healthcare Ltd stock
| Name | March-25 | March-24 | March-23 | March-22 | March-21 |
|---|---|---|---|---|---|
| Assets | 360.5158 | 331.2513 | 284.677 | 217.0627 | 138.6042 |
| Liabilities | 360.5158 | 331.2513 | 284.677 | 217.0627 | 138.6042 |
| Equity | 21.9499 | 21.7499 | 19.04 | 17.118 | 15.618 |
| Gross Profit | 49.6832 | 38.3635 | 33.1422 | 29.4013 | 22.6076 |
| Net Profit | 17.502 | 11.6709 | 12.7586 | 15.2425 | 10.6919 |
| Cash From Operating Activities | 34.0321 | 24.4669 | 33.344 | 35.7876 | 14.5846 |
| NPM(%) | 9.85 | 7.61 | 9.56 | 11.88 | 11.28 |
| Revenue | 177.5847 | 153.3517 | 133.359 | 128.2267 | 94.7393 |
| Expenses | 127.9015 | 114.9882 | 100.2168 | 98.8254 | 72.1316 |
| ROE(%) | 6.6 | 4.4 | 4.81 | 5.75 | 4.03 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Sakar Healthcare Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 855.40 | 0.52 | 28.38 | 0.00 | 301.39 | 0.58 |
| Lotus Eye Hospital and Institute Ltd | 72.06 | -1.95 | 205.89 | 0.00 | 3.55 | 0.00 |
| Vaishali Pharma Ltd | 12.58 | -2.25 | 209.67 | 0.00 | 3.13 | 0.00 |
| Astec Lifesciences Ltd | 808.70 | -0.33 | 0.00 | 0.00 | -687.10 | 0.00 |
Company Info
The Company was incorporated as ?Sakar Healthcare Private Limited? at Ahmedabad, Gujarat as a private limited company under the provisions of the Companies Act, 1956 vide Certificate of Incorporation dated March 26, 2004 bearing corporate identification number U24231GJ2004PTC043861 issued by Registrar of Companies, Gujarat, Dadra and Nagar Haveli. Subsequently, the Company was converted into public company pursuant to shareholders resolution passed in the Extraordinary General Meeting held on March 09, 2015 and the Company was converted into a public limited Company vide fresh certificate of incorporation issued on March 27, 2015 by Registrar of Companies, Gujarat, Ahmedabad and the name of the Company was changed to "Sakar Healthcare Limited". The Corporate Identification Number of the Company is U24231GJ2004PLC043861. Sanjay Shah, Rita Shah and Aarsh Shah are the promoters of the Company. KEY EVENTS AND MILESTONES : The following table sets forth the key events and milestones in the history of the Company, since incorporation: 2004 -Incorporation of the Company. 2005 -The Company received ISO Certification -The Company started commercial production for Plant - 1 which was established for production of Liquid Orals. -The Company started commercially selling its products. 2007 -The Company started exporting its products overseas. 2008 -The Company started commercial production for Plant - 2 which was established for production of Beta Lactum Tablet and Capsules and Dry Syrup B-lactum. / Sachet. -The Company started commercial production for Plant - 3 which was established for production of Liquid Injectibles (SVP) - Ampoules and Liquid Injectibles (SVP) - Vials. 2012 -The Company started commercial production for Plant - 4 which was established for production of Dry Powder Injection. 2015 -Conversion of the Company to a public limited company. 2022-Sakar Healthcare grabed "Pharma Ratna Universe Award - 2022 for Excellence in Oncology Manufacturing".-Sakar Healthcare entered an agreement with Zydus Life Sciences (Cadila Healthcare) to manufacture Oncology (Anti-Cancer) products.2023-Sakar has entered into a contract for One Patented& Second Inovative Oncology Products development and supply with NDDS for Switzerland based Ferring Pharmaceuticalsand Bazell Pharma'.-Sakar enters an agreement with PharOS (Greece) for development of patent non-infringing Oncology product that ranks amongst top-10 in the segment. 2022 -Sakar Healthcare grabs "Pharma Ratna Universe Award - 2022 for Excellence in Oncology Manufacturing". -Sakar Healthcare enters into an agreement with Zydus Life Sciences (Cadila Healthcare) to manufacture Oncology (Anti-Cancer) products. 2023 -'Sakar has entered into a contract for One Patented & Second Inovative Oncology Products development and supply with NDDS for Switzerland based Ferring Pharmaceuticalsand Bazell Pharma'. -Sakar enters an agreement with PharOS (Greece) for development of patent non-infringing Oncology product that ranks amongst top-10 in the segment. 2024 -'Sakar submitted 20 dossiers of oncology product registration across regions covering Switzerland, Bulgaria, Slovenia, Vietnam, Myanmar & Ethiopia'.
The Company was incorporated as ?Sakar Healthcare Private Limited? at Ahmedabad, Gujarat as a private limited company under the provisions of the Companies Act, 1956 vide Certificate of Incorporation dated March 26, 2004 bearing corporate identification number U24231GJ2004PTC043861 issued by Registrar of Companies, Gujarat, Dadra and Nagar Haveli. Subsequently, the Company was converted into public company pursuant to shareholders resolution passed in the Extraordinary General Meeting held on March 09, 2015 and the Company was converted into a public limited Company vide fresh certificate of incorporation issued on March 27, 2015 by Registrar of Companies, Gujarat, Ahmedabad and the name of the Company was changed to "Sakar Healthcare Limited". The Corporate Identification Number of the Company is U24231GJ2004PLC043861. Sanjay Shah, Rita Shah and Aarsh Shah are the promoters of the Company. KEY EVENTS AND MILESTONES : The following table sets forth the key events and milestones in the history of the Company, since incorporation: 2004 -Incorporation of the Company. 2005 -The Company received ISO Certification -The Company started commercial production for Plant - 1 which was established for production of Liquid Orals. -The Company started commercially selling its products. 2007 -The Company started exporting its products overseas. 2008 -The Company started commercial production for Plant - 2 which was established for production of Beta Lactum Tablet and Capsules and Dry Syrup B-lactum. / Sachet. -The Company started commercial production for Plant - 3 which was established for production of Liquid Injectibles (SVP) - Ampoules and Liquid Injectibles (SVP) - Vials. 2012 -The Company started commercial production for Plant - 4 which was established for production of Dry Powder Injection. 2015 -Conversion of the Company to a public limited company. 2022-Sakar Healthcare grabed "Pharma Ratna Universe Award - 2022 for Excellence in Oncology Manufacturing".-Sakar Healthcare entered an agreement with Zydus Life Sciences (Cadila Healthcare) to manufacture Oncology (Anti-Cancer) products.2023-Sakar has entered into a contract for One Patented& Second Inovative Oncology Products development and supply with NDDS for Switzerland based Ferring Pharmaceuticalsand Bazell Pharma'.-Sakar enters an agreement with PharOS (Greece) for development of patent non-infringing Oncology product that ranks amongst top-10 in the segment. 2022 -Sakar Healthcare grabs "Pharma Ratna Universe Award - 2022 for Excellence in Oncology Manufacturing". -Sakar Healthcare enters into an agreement with Zydus Life Sciences (Cadila Healthcare) to manufacture Oncology (Anti-Cancer) products. 2023 -'Sakar has entered into a contract for One Patented & Second Inovative Oncology Products development and supply with NDDS for Switzerland based Ferring Pharmaceuticalsand Bazell Pharma'. -Sakar enters an agreement with PharOS (Greece) for development of patent non-infringing Oncology product that ranks amongst top-10 in the segment. 2024 -'Sakar submitted 20 dossiers of oncology product registration across regions covering Switzerland, Bulgaria, Slovenia, Vietnam, Myanmar & Ethiopia'.
Read More
Parent Organisation
Sakar Healthcare Ltd.
Founded
26/03/2004
Managing Director
Mr.Sanjay S Shah
NSE Symbol
SAKAREQ
FAQ
The current price of Sakar Healthcare Ltd is
The 52-week high for Sakar Healthcare Ltd is
The market capitalization of Sakar Healthcare Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Sakar Healthcare Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Sakar Healthcare Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Sakar Healthcare Ltd shares.
The CEO of Sakar Healthcare Ltd is Mr.Sanjay S Shah, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
